The HAS2 gene promotes breast cancer progression41; in contrast, the LRIG1 gene enhances radiosensitivity in glioblastoma cells through the attenuation of the EGFR/Akt signaling pathway42. The gene discussed is HAS2; the disease is glioblastoma.